EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported fourth-quarter net income of $103 million .
On a per-share basis, the Exton, Pennsylvania -based company said it had net income of $1.36 . Earnings, adjusted for non-recurring costs, came to $1.77 per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.39 per share.
The medical device company posted revenue of $708.7 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $655.2 million .
For the year, the company reported profit of $585.9 million , or $7.73 per share. Revenue was reported as $2.89 billion .
West Pharmaceutical expects full-year earnings in the range of $7.25 to $7.40 per share, with revenue in the range of $2.94 billion to $2.96 billion .
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research . Access a Zacks stock report on WST at https://www.zacks.com/ap/WSTRead more: West Pharmaceutical: Q4 Earnings Snapshot [Associated Press]
This article does not constitute investment advice or a personal recommendation. You should not make any investment decisions without first conducting your own research and considering your own financial situation.
Past performance is not a reliable indicator of future results.
Narrations are not endorsements.